These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 191532)

  • 41. Production of migration inhibition factor (MIF) and an inducer of plasminogen activator (IPA) by subsets of T cells in MLC.
    Newman W; Gordon S; Hämmerling U; Senik A; Bloom BR
    J Immunol; 1978 Mar; 120(3):927-31. PubMed ID: 147297
    [No Abstract]   [Full Text] [Related]  

  • 42. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Induction of T cells--producers of a macrophage migration-inhibitory factor by minor histocompatibility antigens].
    Kharkevich DD; Suslov AP
    Biull Eksp Biol Med; 1984 Dec; 98(12):703-5. PubMed ID: 6391578
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of macrophage migration inhibitory factor (MIF) on acute graft-versus-host disease in a murine model of allogeneic stem cell transplantation.
    Toubai T; Tanaka J; Nishihira J; Ohkawara T; Hirate D; Kondo N; Tone S; Shono Y; Ibata M; Sugita J; Kato N; Miura Y; Iwao N; Ota S; Imamura M
    Transpl Immunol; 2006 Aug; 16(2):117-24. PubMed ID: 16860715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T-cell-mediated antitumor immune response induced by oncofetal antigens.
    Gautam S; Deodhar SD
    J Natl Cancer Inst; 1981 Oct; 67(4):939-45. PubMed ID: 6974275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recognition of protozoan parasites by murine T lymphocytes. II. Role of the H-2 gene complex in interactions between antigen-presenting macrophages and Leishmania-immune T lymphocytes.
    Louis JA; Moedder E; MacDonald HR; Engers HD
    J Immunol; 1981 May; 126(5):1661-6. PubMed ID: 6452473
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunological aspects of Theileria annulata infection calves. 2. Production of macrophage migration inhibition factor (MIF) by sensitized lymphocytes from Theileria annulata-infected calves.
    Rehbein G; Ahmed JS; Schein E; Hörchner F; Zweygarth E
    Tropenmed Parasitol; 1981 Sep; 32(3):154-6. PubMed ID: 6808725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors.
    Holden HT; Haskill JS; Kirchner H; Herberman RB
    J Immunol; 1976 Aug; 117(2):440-6. PubMed ID: 1084897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Strain variations in murine MIF production.
    Adelman N; Cohen S; Yoshida T
    J Immunol; 1978 Jul; 121(1):209-12. PubMed ID: 353191
    [No Abstract]   [Full Text] [Related]  

  • 51. Lymphokine production in primary mixed lymphocyte culture (MLC). III. Alloantigen signals cell-cell interactions involved in migration inhibition factor and immune interferon release.
    Landolfo S; Giovarelli M; Capusso A; Forni G
    Boll Ist Sieroter Milan; 1979 May; 58(2):128-32. PubMed ID: 95480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune reactivity of spleen cells in advanced stages of tumor growth.
    Oisgold-Dagá S; Jasnis MA; Klein S; de Bonaparte YP
    Biomed Pharmacother; 1982; 36(6-7):319-23. PubMed ID: 6763881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunity to murine sarcoma virus-inducted tumors. I. Specific T lymphocytes active in macrophage migration inhibition and lymphocyte transformation.
    Gorczynski RM
    J Immunol; 1974 May; 112(5):1815-25. PubMed ID: 4361977
    [No Abstract]   [Full Text] [Related]  

  • 54. Participation of immunoglobulin-bearing lymphocytes in the production of macrophage migration inhibitory factor.
    Pick E; Godny Y; Gold EF
    Eur J Immunol; 1975 Aug; 5(8):584-7. PubMed ID: 789092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MHC-unrestricted transfer of antilisterial immunity by freshly isolated immune CD8 spleen cells.
    Lukacs K; Kurlander RJ
    J Immunol; 1989 Dec; 143(11):3731-6. PubMed ID: 2479688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.
    Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW
    J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Curative intravenous adoptive immunotherapy of Meth A murine sarcoma. A histologic and immunohistochemical assessment.
    Reichert CM; Rosenstein M; Von Glatz J; Hsu SM; Rosenberg SA
    Lab Invest; 1985 Mar; 52(3):304-13. PubMed ID: 3974201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
    Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K
    J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Production of migration inhibition factor by spleen cells of normal rats upon culture in vitro with tumor cells and cells expressing endogenous virus.
    Sharma JM; Herberman RB; Djeu JY; Nunn ME
    J Immunol; 1979 Jul; 123(1):222-31. PubMed ID: 221590
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.